asset sale
Labcorp Acquiring Enzo Biochem's Clinical Lab Business for $146M
The sale is part of a restructuring initiative that Enzo Biochem launched in 2022 to concentrate on its life science business segment.
Oncocyte Laying off 40 Percent of Staff, Selling DetermaRx Test
The company has entered into a stock purchase agreement to sell 70 percent of its stake in Razor Genomics and has eliminated its COO and CSO positions.
Biora Therapeutics Sells Cell-Free DNA Patents to Roche Diagnostics
The patents are directed to methods and systems for determining the origin of DNA molecules in a cell-free bodily fluid sample.
Myriad Genetics to Sell Vectra DA Business, Reorganize International Presence
The changes follow a strategic review and are part of the company's previously announced plans for growing its revenues and reducing costs.
NantHealth Q1 Revenues Decline 10 Percent
The company turned its first-ever quarterly profit after a series of asset sales and cutbacks in money-losing molecular tests.
Feb 29, 2020
NantHealth Q4 Revenues Grow 6 Percent
Dec 27, 2019
Novacyt Completes Sale of Novaprep Assets
Dec 10, 2019
Enzo Biochem Fiscal Q1 Revenues Down 5 Percent
Oct 27, 2019
Edan Dx Acquires LGC Molecular Diagnostic Platform
Jun 27, 2019
Datavant Partners With Prognos
Jul 24, 2017